Your browser doesn't support javascript.
loading
Characterization of HPV and host genome interactions in primary head and neck cancers.
Parfenov, Michael; Pedamallu, Chandra Sekhar; Gehlenborg, Nils; Freeman, Samuel S; Danilova, Ludmila; Bristow, Christopher A; Lee, Semin; Hadjipanayis, Angela G; Ivanova, Elena V; Wilkerson, Matthew D; Protopopov, Alexei; Yang, Lixing; Seth, Sahil; Song, Xingzhi; Tang, Jiabin; Ren, Xiaojia; Zhang, Jianhua; Pantazi, Angeliki; Santoso, Netty; Xu, Andrew W; Mahadeshwar, Harshad; Wheeler, David A; Haddad, Robert I; Jung, Joonil; Ojesina, Akinyemi I; Issaeva, Natalia; Yarbrough, Wendell G; Hayes, D Neil; Grandis, Jennifer R; El-Naggar, Adel K; Meyerson, Matthew; Park, Peter J; Chin, Lynda; Seidman, J G; Hammerman, Peter S; Kucherlapati, Raju.
Afiliação
  • Parfenov M; Departments of Genetics and.
  • Pedamallu CS; Department of Medical Oncology and The Eli and Edythe L. Broad Institute, Massachusetts Institute of Technology and Harvard University, Cambridge, MA 02142;
  • Gehlenborg N; The Eli and Edythe L. Broad Institute, Massachusetts Institute of Technology and Harvard University, Cambridge, MA 02142; Center for Biomedical Informatics, Harvard Medical School, Boston, MA 02115;
  • Freeman SS; The Eli and Edythe L. Broad Institute, Massachusetts Institute of Technology and Harvard University, Cambridge, MA 02142;
  • Danilova L; The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD 21287;
  • Bristow CA; Institute for Applied Cancer Science, Department of Genomic Medicine and.
  • Lee S; Center for Biomedical Informatics, Harvard Medical School, Boston, MA 02115;
  • Hadjipanayis AG; Departments of Genetics and.
  • Ivanova EV; Department of Medical Oncology and Belfer Institute for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, MA 02115;
  • Wilkerson MD; Lineberger Comprehensive Cancer Center and Department of Genetics and.
  • Protopopov A; Institute for Applied Cancer Science, Department of Genomic Medicine and.
  • Yang L; Center for Biomedical Informatics, Harvard Medical School, Boston, MA 02115;
  • Seth S; Institute for Applied Cancer Science, Department of Genomic Medicine and.
  • Song X; Institute for Applied Cancer Science, Department of Genomic Medicine and.
  • Tang J; Institute for Applied Cancer Science, Department of Genomic Medicine and.
  • Ren X; Departments of Genetics and.
  • Zhang J; Institute for Applied Cancer Science, Department of Genomic Medicine and.
  • Pantazi A; Departments of Genetics and.
  • Santoso N; Departments of Genetics and.
  • Xu AW; Center for Biomedical Informatics, Harvard Medical School, Boston, MA 02115;
  • Mahadeshwar H; Institute for Applied Cancer Science, Department of Genomic Medicine and.
  • Wheeler DA; Human Genome Sequencing Center, Baylor College of Medicine, Houston, TX 77030;
  • Haddad RI; Department of Medical Oncology, Head and Neck Oncology Program, Dana-Farber Cancer Institute, Boston, MA 02215;
  • Jung J; The Eli and Edythe L. Broad Institute, Massachusetts Institute of Technology and Harvard University, Cambridge, MA 02142;
  • Ojesina AI; Department of Medical Oncology and The Eli and Edythe L. Broad Institute, Massachusetts Institute of Technology and Harvard University, Cambridge, MA 02142;
  • Issaeva N; Department of Surgery, Division of Otolaryngology, Yale School of Medicine, New Haven, CT 06520-8041;
  • Yarbrough WG; Department of Surgery, Division of Otolaryngology, Yale School of Medicine, New Haven, CT 06520-8041;
  • Hayes DN; Lineberger Comprehensive Cancer Center and Department of Internal Medicine, Division of Medical Oncology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599;
  • Grandis JR; Departments of Otolaryngology and Pharmacology and Chemical Biology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213; and.
  • El-Naggar AK; Departments of Pathology and Head and Neck Surgery, University of Texas MD Anderson Cancer Center, Houston, TX 77030;
  • Meyerson M; Department of Medical Oncology and The Eli and Edythe L. Broad Institute, Massachusetts Institute of Technology and Harvard University, Cambridge, MA 02142; Pathology and.
  • Park PJ; Center for Biomedical Informatics, Harvard Medical School, Boston, MA 02115;
  • Chin L; The Eli and Edythe L. Broad Institute, Massachusetts Institute of Technology and Harvard University, Cambridge, MA 02142; Institute for Applied Cancer Science, Department of Genomic Medicine and.
  • Seidman JG; Departments of Genetics and seidman@genetics.med.harvard.edu peterh@broadinstitute.org rkucherlapati@partners.org.
  • Hammerman PS; Department of Medical Oncology and The Eli and Edythe L. Broad Institute, Massachusetts Institute of Technology and Harvard University, Cambridge, MA 02142; seidman@genetics.med.harvard.edu peterh@broadinstitute.org rkucherlapati@partners.org.
  • Kucherlapati R; Harvard Medical School, Partners HealthCare Center for Genetics and Genomics, Boston, MA 02115 seidman@genetics.med.harvard.edu peterh@broadinstitute.org rkucherlapati@partners.org.
Proc Natl Acad Sci U S A ; 111(43): 15544-9, 2014 Oct 28.
Article em En | MEDLINE | ID: mdl-25313082
ABSTRACT
Previous studies have established that a subset of head and neck tumors contains human papillomavirus (HPV) sequences and that HPV-driven head and neck cancers display distinct biological and clinical features. HPV is known to drive cancer by the actions of the E6 and E7 oncoproteins, but the molecular architecture of HPV infection and its interaction with the host genome in head and neck cancers have not been comprehensively described. We profiled a cohort of 279 head and neck cancers with next generation RNA and DNA sequencing and show that 35 (12.5%) tumors displayed evidence of high-risk HPV types 16, 33, or 35. Twenty-five cases had integration of the viral genome into one or more locations in the human genome with statistical enrichment for genic regions. Integrations had a marked impact on the human genome and were associated with alterations in DNA copy number, mRNA transcript abundance and splicing, and both inter- and intrachromosomal rearrangements. Many of these events involved genes with documented roles in cancer. Cancers with integrated vs. nonintegrated HPV displayed different patterns of DNA methylation and both human and viral gene expressions. Together, these data provide insight into the mechanisms by which HPV interacts with the human genome beyond expression of viral oncoproteins and suggest that specific integration events are an integral component of viral oncogenesis.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Papillomaviridae / Genoma Humano / Interações Hospedeiro-Patógeno / Neoplasias de Cabeça e Pescoço Limite: Humans Idioma: En Ano de publicação: 2014 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Papillomaviridae / Genoma Humano / Interações Hospedeiro-Patógeno / Neoplasias de Cabeça e Pescoço Limite: Humans Idioma: En Ano de publicação: 2014 Tipo de documento: Article